Next Article in Journal
Serum Myostatin Predicts the Risk of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Multicenter Study
Previous Article in Journal
Assessment of HER2 Protein Overexpression and Gene Amplification in Renal Collecting Duct Carcinoma: Therapeutic Implication
Open AccessReview

BRCA in Gastrointestinal Cancers: Current Treatments and Future Perspectives

Department of Oncology and Hematology, Division of Oncology, University of Modena and Reggio Emilia, 41121 Modena, Italy
*
Author to whom correspondence should be addressed.
Cancers 2020, 12(11), 3346; https://doi.org/10.3390/cancers12113346
Received: 10 October 2020 / Revised: 26 October 2020 / Accepted: 11 November 2020 / Published: 12 November 2020
BRCA gene mutations are progressively gaining more attention in the context of gastrointestinal malignancies, especially in pancreatic cancer where their identification can have both therapeutic and surveillance relevance.
A strong association between pancreatic cancer and BRCA1 and BRCA2 mutations is documented. Based on promising results of breast and ovarian cancers, several clinical trials with poly (ADP-ribose) polymerase inhibitors (PARPi) are ongoing for gastrointestinal (GI) malignancies, especially for pancreatic cancer. Indeed, the POLO trial results provide promising and awaited changes for the pancreatic cancer therapeutic landscape. Contrariwise, for other gastrointestinal tumors, the rationale is currently only alleged. The role of BRCA mutation in gastrointestinal cancers is the subject of this review. In particular, we aim to provide the latest updates about novel therapeutic strategies that, exploiting DNA repair defects, promise to shape the future therapeutic scenario of GI cancers. View Full-Text
Keywords: BRCA1; BRCA2; gastrointestinal cancers; HRD; pancreatic cancer; Olaparib; PARP inhibitors; surveillance BRCA1; BRCA2; gastrointestinal cancers; HRD; pancreatic cancer; Olaparib; PARP inhibitors; surveillance
Show Figures

Graphical abstract

MDPI and ACS Style

Molinaro, E.; Andrikou, K.; Casadei-Gardini, A.; Rovesti, G. BRCA in Gastrointestinal Cancers: Current Treatments and Future Perspectives. Cancers 2020, 12, 3346. https://doi.org/10.3390/cancers12113346

AMA Style

Molinaro E, Andrikou K, Casadei-Gardini A, Rovesti G. BRCA in Gastrointestinal Cancers: Current Treatments and Future Perspectives. Cancers. 2020; 12(11):3346. https://doi.org/10.3390/cancers12113346

Chicago/Turabian Style

Molinaro, Eleonora; Andrikou, Kalliopi; Casadei-Gardini, Andrea; Rovesti, Giulia. 2020. "BRCA in Gastrointestinal Cancers: Current Treatments and Future Perspectives" Cancers 12, no. 11: 3346. https://doi.org/10.3390/cancers12113346

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop